Section Arrow
EDSA.NASDAQ
- Edesa Biotech
Quotes are at least 15-min delayed:2026/07/23 05:17 EDT
Pre Market
Last
 5.55
-0.13 (-2.29%)
Bid
5.45
Ask
5.94
High 5.76 
Low 5.55 
Volume 22 
Regular Hours (Closed)
Last
 5.68
-0.35 (-5.80%)
Day High 
Prev. Close
6.03 
1-M High
8.89 
Volume 
69.86K 
Bid
5.45
Ask
5.94
Day Low
5.5708 
Open
5.94 
1-M Low
5.76 
Market Cap 
58.09M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.69 
20-SMA 7.19 
50-SMA 8.21 
52-W High 20.32 
52-W Low 0.72 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.31/-1.62
Enterprise Value
58.09M
Balance Sheet
Book Value Per Share
0.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LABTLakewood-Amedex Biotherapeutics Inc3.41+1.55+83.33%-- 
Pre Market 3.02 -0.39 -11.44%
KAPAKairos Pharma Ltd.0.3127-0.0453-12.65%-- 
Pre Market 0.2918 -0.0209 -6.68%
JUNSJupiter Neurosciences Inc0.1746+0.0049+2.89%-- 
Pre Market 0.1666 -0.008 -4.58%
GOSSGossamer Bio0.1446-0.0102-6.59%-- 
Pre Market 0.1453 +0.0007 +0.48%
RXRXRecursion Pharmaceuticals2.98-0.1-3.25%-- 
Pre Market 3.0095 +0.0295 +0.99%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.